Live market screen
Commercial Space Company Risk / Opportunity Ranking
Opportunity/risk view across launch, satellites, SAR, earth observation, defense demand, financing events, and execution risk.
Updated June 27, 2026
Opportunity view
Showing rows 201-220 of 438; 20 rows per page.
| Rank | Company | Score | Thesis / Evidence |
|---|---|---|---|
| 201 | Kurs Orbital lowweak | Opp 2 Risk 1 | Thesis: There is limited relevance support that Kurs Orbital is an operating in-orbit servicing company, which could fit a long-horizon commercial space opportunity framework, but the evidence is only undated directory-style article context rather than direct company-specific positive events or facts. Why now: The only retained evidence is an undated external sector index listing Kurs Orbital as operating in in-orbit servicing, so timing and recency are uncertain. Evidence
Caveats: Evidence is undated and the reviewed sources explicitly says undated external evidence is relevance context, not recency proof. Same-article repeated rows are not independent confirmation. No financing, contract, revenue, product milestone, or regulatory evidence is provided. |
| 202 | Leidos Holdings, Inc. lowweak | Opp 2 Risk 1 | Thesis: The reviewed sources rationale says Leidos delivered a cloud-based Joint Management Tool to DISA for SATCOM visibility and modernization, suggesting a role in defense SATCOM infrastructure, but no within the recent evidence window evidence are available to support a stronger long-horizon opportunity thesis. Why now: No surviving evidence are available after the 90-day filter despite 300 articles considered. The rationale cites: and: but no are provided in these reviewed sources. Caveats: Membership rationale is not direct directional proof. No retained evidence after recent evidence window. Cohort fit is ambiguous because support is infrastructure/IT modernization rather than operator economics. |
| 203 | LeoLabs, Inc. lowweak | Opp 2 Risk 1 | Thesis: LeoLabs is described in membership rationale as deploying radar for space domain awareness with Space Force/SpaceWERX support, which is strategically relevant, but no available direct evidence support a stronger opportunity call. Why now: No dated company-specific evidence are available after filtering, so there is no strong timing signal in these reviewed sources. Caveats: No usable evidence after recent evidence window. Membership rationale is insufficient for a high score. |
| 204 | Leonardo S.p.A. lowweak | Opp 2 Risk 1 | Thesis: Older context suggests strategic optionality from self-funding an Earth-observation constellation of 20 radar and IR imagers, but this evidence is outside the 90-day recent evidence window and therefore insufficient for a strong current ranking. Why now: The only concrete company-specific article summary says Leonardo was self-funding a 20-satellite Earth-observation constellation on February 23, 2026, but that date is older than the March 29, 2026 cutoff, so recency is insufficient for a stronger current thesis. Evidence
Caveats: The cited article is outside the 90-day recent evidence window; reviewed sources reports kept_rows 0 and dropped_rows 2. No retained positive or negative evidence exist after filtering. Article-level recap context is weaker than direct event/fact evidence. |
| 205 | Lockheed Martin Corporation lowweak | Opp 2 Risk 2 | Thesis: The reviewed sources membership rationale references space and defense satellite activity that could support long-term opportunity, but no usable recent evidence window-valid evidence are available here. Why now: There is no available why-now evidence within the 90-day recent evidence window; coverage data shows zero evidence after recent evidence window. Caveats: Phase2 rationale cites, and, but no representative articles or evidence are available in the reviewed sources body for citation. Coverage data reports articles after recent evidence window = 0 and evidence after recent evidence window = 0. Low score reflects insufficient current reviewed sources evidence, not a negative fundamental view. |
| 206 | Lux Aeterna lowweak | Opp 2 Risk 2 | Thesis: The membership rationale says Lux Aeterna completed a $10 million seed financing and is building a fully reusable satellite platform, which is directionally positive, but the reviewed sources contain no retained within the recent evidence window article evidence or to support a stronger thesis. Why now: No within the recent evidence window evidence were retained for ranking, so there is no evidence-backed near-term or durable timing edge beyond generic early-stage company progress assumptions. Caveats: Membership rationale references article: but the reviewed sources does not include its or a retained evidence row. |
| 207 | Lynk Global, Inc. lowweak | Opp 2 Risk 2 | Thesis: The reviewed sources say Lynk Global was listed as a payload on a Falcon 9 rideshare mission, which hints at tangible space activity and gives slightly more concrete relevance than pure market-list context, but it still does not establish a supported long-horizon opportunity thesis without direct evidence or. Why now: If a rideshare payload mention reflects program progress, that could matter over 1 year+, but the reviewed sources provide no citable event details, timestamps, quote, or for article ids: and Caveats: A payload mention is more concrete than generic context, but still insufficient here because no direct evidence row or citation is included. No recent evidence window-surviving evidence exists in the reviewed sources. Slight score uplift reflects somewhat more operationally concrete context only. |
| 208 | MBRYONICS Ltd lowweak | Opp 2 Risk 2 | Thesis: There is weak potential opportunity from the reviewed sources' membership rationale that MBRYONICS was a partner on an ESA optical communications project, but the ranking reviewed sources contain no kept direct evidence or citable for that claim. Why now: Why now is weak because only a membership rationale references article about participation in an ESA optical communications project led by Kepler Communications, but no article or reviewed evidence is available for ranking citation. Caveats: Relation-style partnership context cannot be overused as directional proof. No article is provided for article. Coverage after recent evidence window is empty. |
| 209 | Mercury Systems Inc lowweak | Opp 2 Risk 1 | Thesis: The reviewed sources rationale says Mercury supplies solid-state data recorders for SDA tracking satellites, which supports space-program exposure, but there are no retained within the recent evidence window evidence to confirm timing, scale, or durability. Why now: There is no surviving 90-day evidence to establish a current catalyst. The rationale references and: without in these reviewed sources. Caveats: Supplier exposure alone is not enough for a strong positive thesis without direct, timely event evidence. No retained evidence after recent evidence window. |
| 210 | Meridian Space lowweak | Opp 2 Risk 1 | Thesis: The reviewed sources rationale says Meridian Space is a broadband constellation for which 280 satellites are being built, which suggests strategic scale potential, but the actual article evidence is not surfaced in the reviewed sources fields used for ranking, so opportunity support is limited. Why now: Why now is weak because there are no representative articles or available evidence after recent evidence window, and the only support is the membership rationale referencing: without article summary details in the ranking fields. Caveats: No representative article content is included for direct citation beyond membership rationale reference. No direct positive or negative evidence are available after recent evidence window. Scoring is constrained by sparse surfaced evidence. |
| 211 | Motiv Space Systems lowweak | Opp 2 Risk 2 | Thesis: Only a weak opportunity case is supported: undated external article-context lists Motiv Space Systems as an operating in-orbit servicing and assembly company, which suggests continued relevance to the sector but does not prove current growth, contracts, or milestones. Why now: Why now is weak because the only provided evidence is undated context from Space Index identifying Motiv as operating in in-orbit servicing; no recent dated milestone or contract is supplied. Evidence
Caveats: Evidence is undated and supporting article context only. Reviewed evidence membership rationale mentions acquisition by Rocket Lab and robotics products, but no citable evidence are included here for direct ranking use. No current source-cited catalyst was found in the reviewed sources. |
| 212 | Mynaric AG lowweak | Opp 2 Risk 2 | Thesis: Membership rationale describes Mynaric as a laser optical communications terminal provider acquired by Rocket Lab, which implies strategic relevance to space communications hardware, but no direct evidence within the recent evidence window are available to support a durable opportunity call. Why now: No within the recent evidence window retained evidence exists. The reviewed sources references and in the membership rationale, but no or retained evidence are provided here. Caveats: No available direct evidence survived the 90-day recent evidence window. Acquisition/status claim appears only in membership rationale here and cannot be fully evaluated for timing without or timestamps. |
| 213 | Mynaric AG lowweak | Opp 2 Risk 2 | Thesis: The reviewed sources rationale says Mynaric is an acquired laser optical communications company, indicating potentially strategic technology relevance, but there is no direct positive evidence row, quote, or to support a durable opportunity thesis. Why now: Potential relevance depends on the timing and implications of acquisition-related developments, yet the reviewed sources supplies no article summary, or surviving evidence row for article ids, or Caveats: Acquisition-related statements are time-sensitive, but chronology cannot be verified from these reviewed sources because and timestamps are absent at the evidence level. No evidence remain after recent evidence window despite support references being listed. Slight score uplift reflects reviewed sources rationale about optical communications relevance only. |
| 214 | N SPACE TECH lowweak | Opp 2 Risk 2 | Thesis: N SPACE TECH has thematic relevance because the membership rationale profiles it as an Indian aerospace/defense startup designing CubeSats, RF subsystems, radars, and antennas and working with ISRO and DRDO, but the reviewed sources contain no retained 90-day evidence to convert that profile into a current opportunity thesis. Why now: There is no retained within the recent evidence window evidence in the reviewed sources, so there is no demonstrated current catalyst despite the company profile reference. Caveats: Only a membership rationale is present; no recent evidence are retained. Score remains low due to evidence scarcity. |
| 215 | Nanoracks lowweak | Opp 2 Risk 1 | Thesis: The reviewed sources includes one external article summary saying NASA awarded Nanoracks a $160 million contract to develop a commercial space station, which is strategically positive if still relevant, but the article is dated September 2, 2025 and was dropped by the 90-day recent evidence window, so support for a current 1 year+ opportunity ranking is weak. Why now: There is no valid within the recent evidence window catalyst. The only company-specific article is at with September 2, 2025, and the reviewed sources say it was excluded by the 90-day cutoff. Evidence
Caveats: The only cited article is outside the selected 90-day evidence recent evidence window and therefore should not drive strong ranking. This is supporting source context, not merged serving evidence. No retained direct positive or negative evidence remain after recent evidence window. |
| 216 | NordSpace lowweak | Opp 2 Risk 4 | Thesis: Reviewed evidence membership rationale says NordSpace is a private Canadian aerospace/defence startup awarded defense funding for a VLEO satellite concept and planning launches from its own spaceport complex, which would be strategically relevant if current, but no direct evidence or article summaries survived the available recent evidence window in these reviewed sources, so opportunity cannot be ranked highly on evidence alone, unavailable in reviewed sources). Why now: Why now is weak because coverage data shows zero articles after recent evidence window and zero evidence after the 90-day filter, so there is no current catalyst evidence to support a 1 year+ differentiated view from these reviewed sources. Caveats: No article is provided for the membership-support. No direct positive or negative evidence were available after recent evidence window. Private-company status reduces external validation in these reviewed sources. |
| 217 | NorthStar Earth & Space Inc. lowweak | Opp 2 Risk 4 | Thesis: There is not enough in-window evidence in this specific row to support a strong positive thesis beyond generic cohort relevance. Why now: Why-now is weak because the evidence recent evidence review shows zero kept rows after the 90-day cutoff and the row contains no representative articles or direct evidence, so recency and business state are uncertain in these reviewed sources. Caveats: No evidence were available after the recent evidence window for this row. Any statement about public listing, SPAC timing, or operations would be insufficiently grounded from this row alone. Score is driven by evidence absence, not by documented adverse developments. |
| 218 | OHB SE lowweak | Opp 2 Risk 2 | Thesis: OHB may have long-horizon opportunity through satellite manufacturing and in-orbit testing infrastructure exposure, as the membership rationale says Mimir 1 was built by OHB Sweden, but there is no retained 90-day evidence in the reviewed sources to support a current ranking catalyst. Why now: There is no within the recent evidence window retained evidence to establish a fresh catalyst or changing business state. Caveats: Only membership rationale is available; no quoted retained evidence are included. Low score reflects weak current evidence rather than a negative fundamental view. |
| 219 | Optera lowweak | Opp 2 Risk 2 | Thesis: Phase-2 rationale says Optera received UK space-sector early-stage funding and additional private capital, which could be positive if confirmed, but the current reviewed sources retains no in-window evidence to support a stronger ranking. Why now: There is no retained representative article or evidence row inside the current 90-day recent evidence window for Optera, so recency for the claimed funding support is uncertain in these reviewed sources. Caveats: No retained evidence after recent evidence window. Phase-2 membership rationale is not enough for a high-conviction thesis on its own. |
| 220 | Paladin Space lowweak | Opp 2 Risk 2 | Thesis: Reviewed evidence membership rationale says Paladin Space is partnering to offer debris removal as a service using its Triton payload, which suggests exposure to on-orbit servicing and sustainability themes over a long horizon, but no citeable direct evidence are provided. Why now: Why now is weak since the reviewed sources contain no direct post-recent evidence window evidence establishing current deal timing or mission progress. Caveats: One-article universe with no citeable -bearing evidence available. Partnership mention in membership rationale cannot be strongly weighted without direct evidence. |
Risk view
Showing rows 121-140 of 438; 20 rows per page.
| Rank | Company | Score | Thesis / Evidence |
|---|---|---|---|
| 121 | Aalyria Technologies mediumweak | Opp 5 Risk 2 | Thesis: The reviewed sources includes no material negative evidence; the main risk is thin grounding because the conclusion relies on one cited contract-related article without available detail or corroboration. Why now: Current relevance is tied to the cited Space Force Golden Dome contract award context in article, though the reviewed sources omits the and representative article details. Caveats: No article is supplied for the cited support article. Opportunity rests on a single contract-related rationale summary. Contract inclusion alone does not reveal contract size, economics, or conversion pace. |
| 122 | Agnikul lowweak | Opp 3 Risk 2 | Thesis: Risk is moderate because the reviewed sources explicitly says it lacks direct, specific evidence of rocket company operations or a funding/contract event for Agnikul itself in the included material, so the opportunity case is not adequately grounded. Why now: The only timing argument is broad strategic sector positioning in Indian spacetech; there is no validated current catalyst in available evidence. Caveats: Phase-2 rationale references: and: but the reviewed sources does not provide or summaries. Sector beneficiary framing is weaker than direct company event/fact evidence. Coverage debug shows zero evidence after recent evidence window. |
| 123 | Antaris Inc. lowweak | Opp 2 Risk 2 | Thesis: Current ranking risk is mostly uncertainty risk: without retained evidence inside the 90-day window, the reviewed sources does not establish whether the referenced programs are progressing, delayed, funded, or commercially material. Why now: There is no retained 90-day evidence in these reviewed sources despite references to evidence in earlier processing. Recency-sensitive conclusions therefore cannot be made from the local reviewed sources. Caveats: Membership rationale references older evidence but no article IDs are provided with accessible summaries in these reviewed sources body. No representative articles or retained evidence are included. Low score reflects evidence absence, not a negative business judgment. |
| 124 | Apogeo Space lowweak | Opp 4 Risk 2 | Thesis: No material adverse evidence is provided, but the reviewed sources does not show contract economics, execution milestones, or customer traction, so commercialization risk remains. Why now: The reviewed sources' membership rationale cites article: for the integration agreement and technical collaboration, but no article or direct evidence are included. Caveats: Evidence is thin and article-level details are missing. Collaboration and integration agreements are weaker than revenue-bearing customer wins. Single-article support limits conviction. |
| 125 | Arctus Aerospace lowweak | Opp 3 Risk 2 | Thesis: The reviewed sources also explicitly says it is unclear whether Arctus is a true space company versus an atmospheric UAV company. That category ambiguity weakens thesis durability for this specific ranking universe, and no adverse company-specific event is otherwise available. Why now: Funding plus ongoing development could matter over a 1 year+ horizon, but there is no retained dated evidence row to confirm timing, financing close date, or development milestone sequence. Caveats: No current evidence is provided for the cited support article in the reviewed sources. Coverage debug shows articles after recent evidence window = 0 and evidence after recent evidence window = 0. The positive case relies on phase2 rationale rather than retained direct event/facts. |
| 126 | Argotec lowweak | Opp 1 Risk 2 | Thesis: The main risk is evidentiary opacity: no kept structured positive or negative rows are available after recent evidence window, so business-state, traction, and durability are uncertain. Why now: Why now is weak because the reviewed sources show zero evidence kept within the 90-day recent evidence window for ranking, and the only cited support is an older membership rationale referring to 7 Hawk microsatellites for Italy's IRIDE constellation aboard a SpaceX launch from article: but no article or dated evidence row is provided in the reviewed sources for ranking use. Caveats: No article is provided for the membership support article: so it cannot be cited as a factual ranked-evidence item under the the evidence standard. Coverage debug shows zero evidence after recent evidence window. Private/public status is not used as a filter and is unclear from these reviewed sources. |
| 127 | Astranis lowmedium | Opp 4 Risk 2 | Thesis: The evidence is mostly supporting article context rather than strong company-specific event extraction, so execution and conversion risk remain, but there is no direct adverse evidence available. Why now: Recent dated context within the 90-day recent evidence window points to fresh financing and government program inclusion, both relevant for a 1 year+ horizon: Andromeda context on April 8, 2026 and funding context on June 19, 2026 Evidence
Caveats: Evidence is mainly supporting article context, which is weaker than direct event/fact evidence. An older 2025 article about a 2027 transportation deal exists, but it is outside the recent evidence window and not used as current proof. |
| 128 | Astranis Space Technologies lowweak | Opp 2 Risk 2 | Thesis: There is no direct adverse evidence, but the ranking is constrained by zero retained evidence after recent evidence window and potential duplication concerns in the broader article set. Why now: The current batch retains no representative articles or evidence within the 90-day recent evidence window for Astranis, so the reviewed sources does not provide a current dated catalyst despite the phase-2 rationale. Caveats: No retained evidence after recent evidence window. Phase-2 rationale mentions duplicate article versions; duplicates would not be independent confirmation anyway. |
| 129 | Astrobotic Technology lowweak | Opp 2 Risk 2 | Thesis: No material adverse evidence is available in the reviewed sources, so a negative thesis is unsupported. Why now: The rationale references articles, and: but no corresponding available evidence remains available for direct scoring after recent evidence filtering. Caveats: Lunar lander category fit does not equal thesis attractiveness. Coverage debug shows zero available evidence after recent evidence window. Without direct execution, funding, contract-conversion, or mission-status evidence, scores should remain conservative. |
| 130 | Astrolight UAB lowweak | Opp 2 Risk 2 | Thesis: The key risk is that the only described support is partner context, and the reviewed sources explicitly notes the relation row is context-only, leaving no strong basis for a company-specific positive or negative operating thesis. Why now: There is no usable 'why now' beyond possible strategic relevance to optical communications. The reviewed sources provide no after-recent evidence window evidence to confirm current status. Caveats: Phase-2 rationale references, but the reviewed sources does not include its or article summary. Relations marked context-only cannot be used as counterparty propagation evidence. Coverage debug shows zero evidence after recent evidence window. |
| 131 | Azista Industries Private Limited lowweak | Opp 3 Risk 2 | Thesis: The risk is that technical demonstration does not confirm scalable commercial adoption, contracts, or follow-on funding, and none of those are evidenced in the kept reviewed sources rows. Why now: The only support cited is article in the membership rationale. Because the company coverage report shows zero articles after recent evidence window and zero evidence after recent evidence window, there is no robust timing catalyst beyond the historical demonstration narrative. Caveats: Single-article support only, and not available as active evidence. No direct evidence on customer conversion, regulatory adoption, or funding. Private-company visibility is limited in these reviewed sources. |
| 132 | Azista Space lowweak | Opp 2 Risk 2 | Thesis: Risk is mostly uncertainty from minimal coverage: only one article was considered and zero evidence were available after recent evidence window, so durability, backlog, and execution status are unverified here. Why now: Why now is weak because there is no surviving 90-day evidence row in the reviewed sources to establish recency or momentum. Caveats: Only membership rationale is available; no citeable direct evidence with are provided. Single-article universe increases fragility of inference. |
| 133 | Beijing Guodian High-Tech Technology Co lowweak | Opp 4 Risk 2 | Thesis: No direct adverse evidence is provided in the reviewed sources; main risk is limited visibility into commercialization and scale from the single referenced article. Why now: The implied catalyst is the pilot-program approval, but the reviewed sources provide no retained article summary or timestamped evidence row beyond the membership rationale. Caveats: Phase2 membership rationale references: but the actual summary/evidence are absent. Coverage debug shows articles after recent evidence window = 0 and evidence after recent evidence window = 0. Opportunity score is restrained because approval alone is described in rationale but not directly evidenced here. |
| 134 | Bellatrix Aerospace lowweak | Opp 3 Risk 2 | Thesis: Risk is primarily execution and verification uncertainty because the reviewed sources have zero available evidence after recent evidence window, so no current milestone, financing, or contract confirmation is available. Why now: Why now is only moderate in theory because propulsion/platform partnerships can matter over a 1-year-plus horizon, but these reviewed sources does not provide recency-anchored evidence after recent evidence window. Caveats: No direct evidence with available for citation. Technology differentiation is only inferred from membership rationale and is not independently corroborated in available evidence. |
| 135 | Blackstar Orbital lowweak | Opp 2 Risk 2 | Thesis: The main risk is evidence quality: the reviewed sources itself says the evidence is mostly partnership context and lacks direct company-specific operating detail, which weakens any durable 1 year+ thesis. There is still no material adverse event available after recent evidence window. Why now: No near-term or durable catalyst can be established from retained evidence because coverage debug shows zero article IDs and zero evidence after recent evidence window. Caveats: No are provided for the cited support articles in the reviewed sources. The reviewed sources explicitly characterizes the evidence as mostly partnership context rather than direct operating detail. Coverage debug shows articles after recent evidence window = 0 and evidence after recent evidence window = 0. |
| 136 | Boeing highstrong | Opp 8 Risk 2 | Thesis: Source-specific risk is low because there is no available direct adverse evidence tied to Boeing's space thesis in this screen. The main offset is that the contract contributes to a long-cycle program with delivery beginning in 2031, so near-term financial realization is likely gradual rather than immediate, but that is not a negative event Why now: Why now is strong because the contract was reported on June 23-25, 2026, making it recent within the 90-day recent evidence window, and it represents a fresh, material U.S. defense-space award with multiyear strategic relevance Evidence
Caveats: Some corroborating rows are supporting article context and should not be overcounted as independent confirmation. Program financial benefits may phase in over a long cycle given first delivery timing in 2031. |
| 137 | Brightside Group S.A. lowweak | Opp 2 Risk 2 | Thesis: Risk is modest due to lack of current corroborating evidence rather than any adverse development. The reviewed sources contain no direct negative evidence. Why now: Why now is weak because no representative article or direct evidence survives in the ranking fields after recent evidence window; only membership rationale references without surfaced article content. Caveats: No direct within the recent evidence window evidence is available in ranking fields. Membership rationale alone is weaker than surfaced company-specific event evidence. No negative thesis is supportable from the reviewed sources. |
| 138 | CAS Space lowweak | Opp 2 Risk 2 | Thesis: The same rationale says there is little direct company-specific detail beyond inclusion in that group. Without available direct evidence after recent evidence window, the main risk is thesis fragility and inability to verify the claimed IPO/pre-IPO progression. Why now: There is no verified current catalyst in retained evidence. IPO/pre-IPO framing could matter on a 1 year+ horizon, but recency and milestone state cannot be confirmed here because no dated evidence are available after recent evidence window. Caveats: No are provided for the cited support articles in the reviewed sources. Coverage debug shows articles after recent evidence window = 0 and evidence after recent evidence window = 0. IPO/pre-IPO mention is only in reviewed sources rationale, not in retained direct evidence. |
| 139 | Casimir Inc. lowweak | Opp 1 Risk 2 | Thesis: Casimir carries above-peer evidence risk in this screen because the sole cited support is described in the phase2 rationale as blog commentary, and the business fit to the target cohort is explicitly questioned. That weak grounding raises the risk of over-interpreting the financing mention. Why now: There is no available article summary or evidence row after recent evidence window, so the only 'why now' is the uncitable phase2 statement about a seed round referenced by article id: without. Caveats: The reviewed sources itself says the support article is blog commentary, weakening source quality. No citable or summary is provided for the referenced article id No evidence were available after recent evidence window in the served reviewed sources. |
| 140 | constellr mediummedium | Opp 5 Risk 2 | Thesis: Risk remains moderate because the evidence is still supporting article context rather than direct company disclosures about backlog, margins, or contracted demand, and no negative evidence is available. Execution risk remains around converting first-launch and funding momentum into durable commercial scale. Why now: Why now is relatively strongest here because the retained evidence is within the 90-day recent evidence window and dated April 16, 2026, summarizing recent business-state milestones including a first satellite launch in January 2025 and a Series A closed in February 2026. Evidence
Caveats: Evidence is external article context, not a direct company filing or contract announcement. |